human | Q5 |
P11507 | IRIS FBK author ID | 00345 |
P11506 | IRIS UNITN author ID | 00449 |
P496 | ORCID iD | 0000-0001-6915-3070 |
P3829 | Publons author ID | 304603 |
P1053 | ResearcherID | C-6487-2008 |
P1153 | Scopus author ID | 55884911800 |
P735 | given name | Andrea | Q493293 |
Andrea | Q493293 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q91554114 | A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers |
Q39637398 | A multiple classifier system for early melanoma diagnosis. |
Q39721477 | An automated procedure to properly handle digital images in large scale tissue microarray experiments. |
Q57693440 | Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer |
Q57314640 | Automatic model selection in cost-sensitive boosting |
Q95601997 | Building an International Consortium for Tracking Coronavirus Health Status |
Q96128119 | Building an international consortium for tracking coronavirus health status |
Q39688600 | Clinical validation of an automated system for supporting the early diagnosis of melanoma. |
Q41315076 | Clonal evolution of chemotherapy-resistant urothelial carcinoma. |
Q33610866 | Comparison and calibration of transcriptome data from RNA-Seq and tiling arrays |
Q64073046 | Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer |
Q34452282 | Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing |
Q37173727 | Distinct genomic aberrations associated with ERG rearranged prostate cancer |
Q38768101 | Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer |
Q27939657 | Diverse protein kinase interactions identified by protein microarrays reveal novel connections between cellular processes |
Q36730577 | Epigenomic alterations in localized and advanced prostate cancer |
Q34775924 | Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer |
Q27499410 | FusionSeq: a modular framework for finding gene fusions by analyzing Paired-End RNA-Sequencing data |
Q112713263 | G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer |
Q21144925 | Genomic analysis of the hydrocarbon-producing, cellulolytic, endophytic fungus Ascocoryne sarcoides |
Q28254700 | Genomics and privacy: implications of the new reality of closed data for the field |
Q34125015 | IQSeq: integrated isoform quantification analysis based on next-generation sequencing |
Q34212750 | Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma |
Q57693316 | Identifying an ERG-positive Subclass with Clinical Progression Using Expression Profiling |
Q112642696 | Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer |
Q28301622 | Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project |
Q22065599 | Integrative annotation of variants from 1092 humans: application to cancer genomics |
Q27853170 | Integrative clinical genomics of advanced prostate cancer |
Q46920853 | Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer |
Q39385550 | Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets |
Q33541296 | Molecular sampling of prostate cancer: a dilemma for predicting disease progression |
Q28771715 | N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer |
Q24647034 | N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer |
Q41867966 | Novel MIR143-NOTCH fusions in benign and malignant glomus tumors |
Q33874474 | Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma |
Q112713949 | Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer |
Q34545103 | Organoid cultures derived from patients with advanced prostate cancer |
Q55367999 | Patient derived organoids to model rare prostate cancer phenotypes. |
Q38885294 | Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine |
Q96766154 | Publisher Correction: Building an international consortium for tracking coronavirus health status |
Q92451836 | Publisher Correction: The long tail of oncogenic drivers in prostate cancer |
Q36950514 | Punctuated evolution of prostate cancer genomes |
Q33764103 | RSEQtools: a modular framework to analyze RNA-Seq data using compact, anonymized data summaries |
Q50943467 | Re: Stoehr et al. Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients. J Pathol 2013; 230: 453-456. |
Q37072709 | Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma |
Q84688558 | Robust-linear-model normalization to reduce technical variability in functional protein microarrays |
Q101216831 | Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity |
Q90008246 | SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy |
Q51099413 | SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling. |
Q47333876 | SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. |
Q36210354 | SPOP mutation leads to genomic instability in prostate cancer. |
Q37584305 | SPOP mutations in prostate cancer across demographically diverse patient cohorts. |
Q24617949 | The genomic complexity of primary human prostate cancer |
Q52611753 | The long tail of oncogenic drivers in prostate cancer. |
Q35632563 | The real cost of sequencing: higher than you think! |
Q42924615 | The role of disorder in interaction networks: a structural analysis |
Q30587156 | Unraveling the clonal hierarchy of somatic genomic aberrations. |
Q36186603 | VAT: a computational framework to functionally annotate variants in personal genomes within a cloud-computing environment |
Search more.